Recent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk localized, muscle-invasive disease, according to a new editorial.
The launch of emerging therapies, such as LNZ100 by Lenz Therapeutics, Phentolamine Ophthalmic Solution 0.75% by Viatris an ...
The UChicago Medicine team will be led by Odunsi as co-principal investigator and includes Christopher Weber, Savas Tay, and ...
Regeneron’s clinical trials are at the core of this mission. Regeneron is grateful to all clinical trial participants — ...
University of Sheffield spinout company, Rinri Therapeutics, a company focused on developing new treatments for hearing loss ...
Analyst Jack Allen from Robert W. Baird maintained a Buy rating on Mereo Biopharma Group Plc (MREO – Research Report) and keeping the ...
With a bachelor's degree in nursing, you can pursue a wide variety of paths, from bedside care to corporate roles.
His extensive experience in the MedTech industry and proven leadership in guiding companies through significant growth phases make him an invaluable ... The Maryland Stem Cell Research Commission ...
Phase 1: Discovery and Preclinical Phases: Identification and testing of potential drug compounds. Duration: 1 to 6 years.
H.C. Wainwright analyst Emily Bodnar maintained a Buy rating on Atossa Therapeutics (ATOS – Research Report) today and set a price target ...
Research Program: Nitric Oxide Formulation, AROMUC 5AC, Lonodelestat, AZD-0292, CSL 787, Inhaled Murepavadin, NM001, SPL 5AC, Mucolytic Agents, and others are under different phases of non-cystic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback